aap Implantate Narrows 2026 Revenue Forecast to EUR 12 Million–EUR 13 Million

• aap Implantate narrowed its 2026 revenue forecast to EUR 12 million–EUR 13 million from EUR 11.5 million–EUR 14.5 million.
• EBITDA guidance tightened to a EUR 500,000 loss–EUR 500,000 profit from a EUR 1 million loss–EUR 1.5 million profit.
• For 2027, revenue is expected at least EUR 14 million, with EBITDA of EUR 0–EUR 2 million.
• The 2030 target calls for revenue of at least EUR 21 million, with a steady-state EBITDA margin of 17.5%–22.5%.
• Nine-month revenue totaled EUR 9.35 million versus EUR 9.48 million a year earlier; IFRS EBITDA exceeded break-even.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. aap Implantate AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2431806_en) on November 11, 2026, and is solely responsible for the information contained therein.